March 11, 2021
Biden Administration - What's Ahead for the Life Sciences Industry?
February 3, 2021
Implementation of Final Rule Excluding PBM Rebates from Discount Safe Harbor Delayed Until 2023
December 31, 2020
Final Rule on VBP, Patient Assistance and Line Extensions Presents Opportunity and Risk for Drug Manufacturers
December 14, 2020
HHS Finalizes 340B Administrative Dispute Resolution Process
November 25, 2020
HHS Finalizes Rule Challenging Drug Manufacturer Rebates to PBMs and Payors
November 23, 2020
He Actually Did It: Trump Administration Implements Medicare Part B “Most Favored Nation” Drug Pricing Reform
July 30, 2020
Trump Administration Continues to Promote Drug Importation as a Way to Lower the Cost of Prescription Drugs
June 23, 2020
New Risks, New Rewards, New Exposure
January 16, 2020
HHS Drug Import Proposal Is Unlikely To Succeed
January 7, 2020
FDA Issues Proposed Rule and Draft Guidance on Drug Importation
April 21, 2017
New York Institutes New Medicaid Drug Price Control Measures
January 6, 2017
HRSA Issues Final Rule on Calculation of 340B Ceiling Prices and Manufacturer Civil Monetary Penalties